Anis Barmada is an M.D./Ph.D. student and P.D. Soros Fellow in the Department of Immunobiology at the Yale University School of Medicine in New Haven, Connecticut. He completed his B.S. at the University of Illinois at Chicago in the United States in biology, chemistry, and mathematics. He then completed an M.Phil. in Genomic Medicine with distinction at the University of Cambridge and Wellcome Sanger Institute in the United Kingdom as a Gates Cambridge Scholar, where he worked in the laboratory of Dr. Roser Vento-Tormo on elucidating immune signatures in COVID-19 using single-cell approaches. He most recently led the investigation into immune signatures and drivers of SARS-CoV-2 mRNA vaccine-associated myocarditis in the laboratory of Dr. Carrie Lucas at the Yale School of Medicine. Anis currently serves as the Editor-in-Chief of the Yale Journal of Biology and Medicine, and he has contributed many science communication pieces in media outlets such as Scientific American and The Scholar.
